Most notably, reduced STAT1 was observed in severe COVID‐19 cases compared to mild COVID‐19 cases, in particular, in CD14+ monocytes and plasmablasts, respectively (Fig 1D and E). This evidence concerns the gene STAT1 and COVID-19.